I A Olivotto

Summary

Affiliation: British Columbia
Country: Canada

Publications

  1. ncbi Screening Mammography Program of British Columbia: pattern of use and health care system costs
    I A Olivotto
    Screening Mammography Program of British Columbia, Vancouver
    CMAJ 160:337-41. 1999
  2. ncbi Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy
    Ivo A Olivotto
    BC Cancer Agency Vancouver Island Centre, Victoria, British Columbia, Canada
    J Clin Oncol 27:16-23. 2009
  3. ncbi Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer
    Ivo A Olivotto
    Breast Cancer Outcomes Unit, Victoria, British Columbia, Canada
    J Clin Oncol 21:851-4. 2003
  4. ncbi A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial
    Ivo A Olivotto
    Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada
    Clin Breast Cancer 4:361-3. 2003
  5. ncbi Population-based validation of the prognostic model ADJUVANT! for early breast cancer
    Ivo A Olivotto
    Breast Cancer Outcomes Unit, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada
    J Clin Oncol 23:2716-25. 2005
  6. ncbi Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia
    I A Olivotto
    The Screening Mammography Program of British Columbia, British Columbia Cancer Agency, The University of British Columbia, Vancouver, Canada
    Breast Cancer Res Treat 54:73-81. 1999
  7. ncbi Waiting for a diagnosis after an abnormal screening mammogram. SMPBC diagnostic process workgroup. Screening Mammography Program of British Columbia
    I A Olivotto
    University of British Columbia, Vancouver
    Can J Public Health 91:113-7. 2000
  8. ncbi Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97
    I A Olivotto
    Screening Mammography Program of British Columbia BC, 8th Floor, 686 West Broadway, Vancouver, BC, Canada V5Z 1G1
    J Med Screen 7:152-9. 2000
  9. ncbi Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse
    H A Kader
    Breast Cancer Outcomes Unit, Vancouver Island Cancer Center, Victoria, Canada
    Breast J 7:8-13. 2001
  10. ncbi Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy
    Pauline T Truong
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 73:357-64. 2009

Detail Information

Publications92

  1. ncbi Screening Mammography Program of British Columbia: pattern of use and health care system costs
    I A Olivotto
    Screening Mammography Program of British Columbia, Vancouver
    CMAJ 160:337-41. 1999
    ..This report describes the changes that have occurred in the use of bilateral mammography in British Columbia since the provincial breast cancer screening program began in 1988...
  2. ncbi Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy
    Ivo A Olivotto
    BC Cancer Agency Vancouver Island Centre, Victoria, British Columbia, Canada
    J Clin Oncol 27:16-23. 2009
    ..To determine the interval from breast-conserving surgery (BCS) to radiation therapy (RT) that affects local control or survival...
  3. ncbi Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer
    Ivo A Olivotto
    Breast Cancer Outcomes Unit, Victoria, British Columbia, Canada
    J Clin Oncol 21:851-4. 2003
    ....
  4. ncbi A clinical trial of breast radiation therapy versus breast plus regional radiation therapy in early-stage breast cancer: the MA20 trial
    Ivo A Olivotto
    Radiation Oncology, British Columbia Cancer Agency and University of British Columbia, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada
    Clin Breast Cancer 4:361-3. 2003
  5. ncbi Population-based validation of the prognostic model ADJUVANT! for early breast cancer
    Ivo A Olivotto
    Breast Cancer Outcomes Unit, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada
    J Clin Oncol 23:2716-25. 2005
    ..Adjuvant! (www.adjuvantonline.com) is a web-based tool that predicts 10-year breast cancer outcomes with and without adjuvant systemic therapy, but it has not been independently validated...
  6. ncbi Prognosis, treatment, and recurrence of breast cancer for women attending or not attending the Screening Mammography Program of British Columbia
    I A Olivotto
    The Screening Mammography Program of British Columbia, British Columbia Cancer Agency, The University of British Columbia, Vancouver, Canada
    Breast Cancer Res Treat 54:73-81. 1999
    ..These favorable surrogate endpoints suggest that the benefits of breast screening as demonstrated by randomized trials can be translated into community practice by an organized breast screening program...
  7. ncbi Waiting for a diagnosis after an abnormal screening mammogram. SMPBC diagnostic process workgroup. Screening Mammography Program of British Columbia
    I A Olivotto
    University of British Columbia, Vancouver
    Can J Public Health 91:113-7. 2000
    ..This report evaluated the timeliness of diagnosis after an abnormal screening mammogram in the Screening Mammography Program of British Columbia (SMPBC)...
  8. ncbi Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97
    I A Olivotto
    Screening Mammography Program of British Columbia BC, 8th Floor, 686 West Broadway, Vancouver, BC, Canada V5Z 1G1
    J Med Screen 7:152-9. 2000
    ..To evaluate 10 years outcomes of the Screening Mammography Program of British Columbia (SMPBC) and determine if breast screening targets were being achieved among women aged 40-80+ years...
  9. ncbi Tubular carcinoma of the breast: a population-based study of nodal metastases at presentation and of patterns of relapse
    H A Kader
    Breast Cancer Outcomes Unit, Vancouver Island Cancer Center, Victoria, Canada
    Breast J 7:8-13. 2001
    ..In view of the low incidence of axillary node metastases at presentation in the low-risk TCB subset (7%), axillary dissection may be omitted as part of the initial surgical management in these patients...
  10. ncbi Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy
    Pauline T Truong
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 73:357-64. 2009
    ..To evaluate locoregional recurrence according to nodal status in women with T1 to T2 breast cancer and zero to three positive nodes (0-3N+) treated with breast-conserving surgery (BCS)...
  11. ncbi Improving the time to diagnosis after an abnormal screening mammogram
    I A Olivotto
    Screening Mammography Program of British Columbia, Victoria, BC
    Can J Public Health 92:366-71. 2001
    ..CONCLUSIONS: Process changes can improve the time to diagnosis after an abnormal breast screen, with similar or lower physician costs per subject. Facilitating the referral process had the greatest impact...
  12. ncbi Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy
    Pauline T Truong
    British Columbia Cancer Agency-Vancouver Island Centre and the Department of Surgery, University of British Columbia, Victoria, BC, Canada
    J Am Coll Surg 200:912-21. 2005
    ..Prospective research is required to define the role of adjuvant radiotherapy in these patients...
  13. ncbi Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy
    Pauline T Truong
    Radiation Therapy Program, Vancouver Island Centre, British Columbia Cancer Agency and the University of British Columbia, 2410 Lee Avenue, Victoria, BC, Canada V8R 6V5
    Eur J Cancer 41:1267-77. 2005
    ..Chronologic age alone should not preclude these women from consideration of adjuvant radiotherapy...
  14. ncbi Increased use of adjuvant regional radiotherapy for node-positive breast cancer in British Columbia
    Boon Chua
    Radiation Therapy and Systemic Therapy Programs, British Columbia Cancer Agency, Vancouver Island Center, Victoria, British Columbia, Canada
    Breast J 10:38-44. 2004
    ..001 for both). Publication of randomized trials and a coordinated guideline implementation process in British Columbia was associated with a significant increase in the use of regional RT in women with one to three positive nodes...
  15. ncbi Management and outcomes of isolated axillary node recurrence in breast cancer
    David E Konkin
    Division of Surgical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
    Arch Surg 141:867-72; discussion 872-4. 2006
    ..0%. Multimodality management at the time of recurrence, including axillary surgery, radiation, and systemic therapy, significantly improved overall and disease-free survival...
  16. ncbi Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study
    M L Lesperance
    Department of Mathematics and Statistics, University of Victoria, Victoria, British Columbia, Canada
    Breast Cancer Res Treat 76:137-43. 2002
    ..Alternative therapies such as mega-dose vitamins and minerals are commonly used by women with breast cancer, but their effect on recurrence and survival have rarely been evaluated...
  17. ncbi Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer
    C Lohrisch
    Breast Cancer Outcomes Unit and Systemic and Radiation Therapy Programs of the British Columbia Cancer Agency, and Fraser Valley Cancer Centers and the Faculty of Medicine, University of British Columbia, Vancouver, Canada
    J Clin Oncol 18:2828-35. 2000
    ..To explore the independent prognostic impact of medial hemisphere tumor location in early breast cancer...
  18. ncbi T1a breast carcinoma and the role of axillary dissection
    Nathan P Schneidereit
    Department of Surgery, University of British Columbia, Vancouver
    Arch Surg 138:832-7. 2003
    ..70) or survival (P =.84). CONCLUSION: Higher tumor grade and lymphovascular and/or neural invasion increased the rate of nodal metastases in T1a tumors, but AD did not improve relapse rates or breast cancer-specific survival...
  19. ncbi Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?
    W Kwan
    Radiation Therapy Program, Fraser Valley Centre, British Columbia, Canada
    Ann Oncol 21:988-93. 2010
    ..The impact of HER2 overexpression on the locoregional control of breast cancer is controversial...
  20. ncbi Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis
    Miguel Panades
    Breast Cancer Outcomes Unit, BC Cancer Agency-Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC, Canada
    J Clin Oncol 23:1941-50. 2005
    ..02), and CT type (P = .05). CONCLUSION: This retrospective analysis suggested that mastectomy, in conjunction with CT and RT, seemed to enhance locoregional control, whereas modern CT regimens seemed to improve BCSS...
  21. ncbi 3D ultrasound can contribute to planning CT to define the target for partial breast radiotherapy
    Tanya S Berrang
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 73:375-83. 2009
    ....
  22. ncbi Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation
    T Vu
    Provincial Systemic Therapy Program, BC Cancer Agency, Vancouver, British Columbia, Canada
    Ann Oncol 19:461-4. 2008
    ..A randomized controlled trial showed longer overall survival (OS) with docetaxel compared with paclitaxel in metastatic breast cancer patients with prior exposure to anthracycline. We report a similar comparison using population-based data...
  23. ncbi Comparison of 1- and 2-year screening intervals for women undergoing screening mammography
    E S Wai
    Radiation Therapy Program, BC Cancer Agency, Vancouver Island Centre, 2410 Lee Ave, Victoria, BC, Canada V8R 6V5
    Br J Cancer 92:961-6. 2005
    ..Annual compared to biennial mammography was associated with a 1.2% increase in the estimated 10-year breast cancer-specific survival for women aged 50-74 years, diagnosed with invasive breast cancer after screening programme attendance...
  24. ncbi Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema
    S R Harris
    School of Rehabilitation Sciences, Faculty of Medicine, University of British Columbia, Vancouver, BC
    CMAJ 164:191-9. 2001
    ..SPONSOR: The steering committee was convened by Health Canada. COMPLETION DATE: October 2000...
  25. ncbi Is mastectomy superior to breast-conserving treatment for young women?
    Genevieve Coulombe
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver, BC, Canada
    Int J Radiat Oncol Biol Phys 67:1282-90. 2007
    ..To examine whether modified radical mastectomy (MRM) improves outcomes compared with breast-conserving treatment (BCT) in young women...
  26. ncbi Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival
    Maggie C U Cheang
    Genetic Pathology Evaluation Centre at Vancouver General Hospital, Prostate Centre, and University of British Columbia, Vancouver, British Columbia, Canada
    J Clin Oncol 24:5637-44. 2006
    ..CONCLUSION: SP1 represents an improved standard for ER immunohistochemistry assessment in breast cancer...
  27. ncbi Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001
    Boon Chua
    Radiation Therapy Program, BC Cancer Agency, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC, V8R 6V5, Canada
    Am J Surg 185:118-26. 2003
    ..Increasing surgeon experience was not significantly associated with improvements in identification or false-negative rates. CONCLUSIONS: The potential of SNB was not fully translated into surgical practice in BC by 2001...
  28. ncbi Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma
    Ivo A Olivotto
    Screening Mammography Program of British Columbia, British Columbia Cancer Agency, Vancouver British Columbia, Canada
    Cancer 94:2143-50. 2002
    ..Suspicion bias should be considered when interpreting the effect of delay on prognosis...
  29. ncbi Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces
    I A Olivotto
    Division of Radiation Oncology, University of British Columbia, Vancouver, BC
    CMAJ 165:277-83. 2001
    ..To ensure that targets for timeliness, adopted nationally in 1999, are realized, improved models of care or dissemination of existing efficient techniques to reach a diagnosis will be needed...
  30. ncbi A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
    G Macdonald
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Cancer Centre, BC, Canada
    Ann Oncol 16:1442-8. 2005
    ..The aim was to determine whether gender was a significant prognostic factor for post-mastectomy relapse, after accounting for known prognostic factors and delivery of radiotherapy...
  31. ncbi Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer
    L Weir
    Radiation Therapy Program, Breast Cancer Outcomes Unit, University of British Columbia, Vancouver, British Columbia, Canada
    J Clin Oncol 20:1793-9. 2002
    ..The objective of the study was to evaluate the association between the number of lymph nodes removed at axillary dissection and recurrence and survival for patients with node-negative invasive breast cancer...
  32. ncbi Postmastectomy radiotherapy reduces locoregional recurrence in elderly women with high-risk breast cancer
    J C Lee
    Radiation Therapy Program, Vancouver Island Centre, British Columbia Cancer Agency, Canada
    Clin Oncol (R Coll Radiol) 17:623-9. 2005
    ..PMRT should be considered in the management of elderly women with these high-risk characteristics...
  33. ncbi Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen
    H F Kennecke
    Division of Medical Oncology, British Columbia BC Cancer Agency, Canada
    Ann Oncol 18:45-51. 2007
    ..An individualized estimate of the risk of relapse and death after 5 years of tamoxifen could improve decisions regarding extended hormonal therapy...
  34. ncbi Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, Short-Form McGill Pain Questionnaire, and patients' perspectives
    Pauline T Truong
    British Columbia Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada
    Plast Reconstr Surg 116:1291-9. 2005
    ..This article evaluates the application of the Vancouver Scar Scale, in conjunction with patients' scar self-rating and scar-related pain, in a cohort of breast cancer patients...
  35. ncbi Increased use of regional radiotherapy is associated with improved outcome in a population-based cohort of women with breast cancer with 1-3 positive nodes
    Elaine S Wai
    BC Cancer Agency, Vancouver Island Centre, Radiation Therapy Program, Canada
    Radiother Oncol 97:301-6. 2010
    ....
  36. ncbi Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer
    Pauline T Truong
    British Columbia Cancer Agency, Vancouver Island Centre, British Columbia Cancer Agency, 2410 Lee Avenue, Victoria, BC, Canada V8R 6V5
    Am J Surg 191:749-55. 2006
    ..To evaluate the effect of radiotherapy (RT) omission on survival in older breast cancer patients treated with breast-conserving surgery...
  37. ncbi Does a three-field electron/minitangent photon technique offer dosimetric advantages to a multifield, photon-only technique for accelerated partial breast irradiation?
    Aminudin R Mydin
    Vancouver Island Centre, Victoria, British Columbia, Canada
    Am J Clin Oncol 33:336-40. 2010
    ..To determine whether 3-field electron/minitangent photons (mixed-modality) technique improved dosimetry compared with a multifield, photon-only technique for accelerated partial breast irradiation (APBI)...
  38. ncbi Effect of radiotherapy boost and hypofractionation on outcomes in ductal carcinoma in situ
    Elaine S Wai
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Center, Victoria, British Columbia, Canada
    Cancer 117:54-62. 2011
    ..This study examined outcomes from whole breast RT, with or without a boost, and the impact of different dose-fractionation schedules in a population-based cohort of women with pure DCIS treated with breast-conserving surgery (BCS)...
  39. ncbi Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer
    Caroline Lohrisch
    Breast Cancer Outcomes Unit, British Columbia Cancer Agency, Vancouver
    J Clin Oncol 24:4888-94. 2006
    ..To determine if time to start of adjuvant chemotherapy after curative surgery influences survival in early-stage breast cancer...
  40. ncbi Reliability and validity testing of the Patient and Observer Scar Assessment Scale in evaluating linear scars after breast cancer surgery
    Pauline T Truong
    British Columbia Cancer Agency, Vancouver Island Centre, Department of Surgery, University of British Columbia, Canada
    Plast Reconstr Surg 119:487-94. 2007
    ..The authors compared this tool to the Vancouver Scar Scale in a cohort of women with linear scars from breast cancer surgery...
  41. ncbi Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes
    Carmen C Popescu
    Radiation Therapy Program, British Columbia Cancer Agency Vancouver Island Centre, Victoria, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 76:287-95. 2010
    ..This study compared VMAT with cIMRT and with conventional modified wide-tangent (MWT) techniques for locoregional radiotherapy for left-sided breast cancer, including internal mammary nodes...
  42. ncbi Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
    Hagen Kennecke
    Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    Cancer 112:1437-44. 2008
    ..An understanding of which patients are at risk of early recurrence while they are receiving tamoxifen may improve clinical decision making...
  43. ncbi Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers
    Stephen Chia
    Division of Medical Oncology, Breast Cancer Outcomes Unit, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada
    J Clin Oncol 26:5697-704. 2008
    ..This study assessed the prognostic impact of HER2 overexpression/amplification in a large series of node-negative breast cancers...
  44. ncbi Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence
    Rinat Yerushalmi
    Division of Medical Oncology, British Columbia Cancer Agency, 600 W 10th Avenue, Vancouver, BC, Canada V5Z 4E6
    Breast Cancer Res Treat 117:365-70. 2009
    ..174 (95% CI 1,004, 1.372). Conclusions M/M breast cancer did not increase the risk of metachronous CBC, but was associated with inferior BCSS...
  45. ncbi Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?
    Wayne A Beckham
    Radiation Therapy Program of the British Columbia Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 69:918-24. 2007
    ..The value of conformal intensity-modulated radiation therapy (IMRT) to avoid heart dose was studied...
  46. ncbi Target volume delineation for partial breast radiotherapy planning: clinical characteristics associated with low interobserver concordance
    Ross P Petersen
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, Victoria, Canada
    Int J Radiat Oncol Biol Phys 69:41-8. 2007
    ..To examine variability in target volume delineation for partial breast radiotherapy planning and evaluate characteristics associated with low interobserver concordance...
  47. ncbi The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer
    Stephen K Chia
    Division of Medical Oncology, British Columbia Cancer Agency and the University of British Columbia, Vancouver and Victoria, British Columbia, Canada
    Cancer 110:973-9. 2007
    ..This study characterized the use and assessed the impact on survival of population-based access to new agents for the treatment of MBC...
  48. ncbi Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen
    Mandana Saadat
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, British Columbia, Canada
    Cancer 110:31-7. 2007
    ..The study compared tumor characteristics and survival in women with breast cancer who subsequently developed endometrial cancer with or without a history of tamoxifen use...
  49. ncbi The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis of prospective data from British Colum
    Pauline T Truong
    Department of Radiation Oncology, British Columbia Cancer Agency Vancouver Island Centre, British Columbia Cancer Agency, University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 68:59-65. 2007
    ....
  50. ncbi Impact of changing from annual to biennial mammographic screening on breast cancer outcomes in women aged 50-79 in British Columbia
    Andrew J Coldman
    Surveillance and Outcomes Unit, British Columbia Cancer Agency, Suite 800, 686 W Broadway, Vancouver, BC V5Z 1G1, Canada
    J Med Screen 15:182-7. 2008
    ..The objective of this study was to compare breast cancer outcomes among women subject to different policies on mammography screening frequency...
  51. ncbi When is CT-based postoperative seroma most useful to plan partial breast radiotherapy? Evaluation of clinical factors affecting seroma volume and clarity
    Hosam A Kader
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 72:1064-9. 2008
    ..To evaluate the effect of the time from surgery and other clinical factors on seroma volume and clarity and establish the optimal time to use the computed tomography (CT)-based seroma to plan partial breast irradiation (PBI)...
  52. ncbi The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes
    Pauline T Truong
    British Columbia Cancer Agency, Vancouver Island Center, Radiation Therapy Program and the University of British Columbia, Victoria, British Columbia, Canada
    Cancer 103:2006-14. 2005
    ..The current study evaluated the prognostic impact of the percentage of positive/dissected lymph nodes on recurrence and survival in women with one to three positive lymph nodes...
  53. ncbi Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer
    Eric Berthelet
    Radiation Therapy and Systemic Therapy Programs, British Columbia Cancer Agency, Vancouver Island and Fraser Valley Centres, Victoria, BC, Canada
    Am J Clin Oncol 29:21-6. 2006
    ..To examine time intervals between diagnosis and treatment of limited stage small cell lung cancer (L-SCLC) and to evaluate its effect on clinical outcomes...
  54. ncbi Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia
    Janessa J Laskin
    Division of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6
    Lung Cancer 43:7-16. 2004
    ..4 months (7.3 and 2.3% for 2- and 5-year survival, respectively). Standard treatment guidelines generated population-based survival outcomes that are similar to published clinical trials...
  55. ncbi A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer
    Pauline T Truong
    Breast Cancer Outcomes Unit, British Columbia Cancer Agency Vancouver Island Centre and the University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 58:797-804. 2004
    ..This study examined relapse and survival among women with node-negative breast cancer and positive surgical margins after mastectomy...
  56. ncbi Endoscopic response predicts for survival and organ preservation after primary chemoradiotherapy for esophageal cancer
    Jan T W Lim
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, Victoria, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 57:1328-35. 2003
    ..To determine the role of endoscopic surveillance in predicting organ preservation and survival after primary chemoradiotherapy (CRT) for esophageal cancer...
  57. ncbi Waist-to-hip ratio and breast cancer mortality
    Marilyn J Borugian
    Cancer Control Research Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
    Am J Epidemiol 158:963-8. 2003
    ..Elevated WHR was confirmed as a predictor of breast cancer mortality, with menopausal status and ER status at diagnosis found to be important modifiers of that relation...
  58. ncbi Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies
    Stephen K Chia
    Division of Medical Oncology, Breast Cancer Outcomes Unit, British Columbia Cancer Agency, 600 West 10th Ave, Vancouver, BC Canada, V5Z 4E6
    J Clin Oncol 22:1630-7. 2004
    ..We assessed the 10-year outcomes in a population-based cohort of node-negative (N-) lymphovascular negative (LV-) early breast cancers diagnosed from 1989 to 1991 who did not receive adjuvant systemic therapy...
  59. ncbi Local and regional therapy for women with breast cancer in British Columbia
    T Gregory Hislop
    Population and Preventative Oncology Program, BC Cancer Agency, Vancouver, British Columbia, Canada
    Breast J 9:192-9. 2003
    ..The increase in BCS, and high proportion completing radiation therapy, are encouraging and may be due in part to greater exposure to PPGs...
  60. ncbi Satisfaction and anxiety for women during investigation of an abnormal screening mammogram
    T Gregory Hislop
    Cancer Control, BC Cancer Agency, Vancouver, British Columbia, Canada
    Breast Cancer Res Treat 76:245-54. 2002
    ..Differences were found between biopsied and nonbiopsied women for several of these measures. Shortening the time to diagnosis positively influenced the client's perception of unnecessary delay...
  61. ncbi Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life
    Winkle Kwan
    Radiation Therapy Program, Surgical Oncology Program, and Breast Cancer Outcomes Unit of the British Columbia Cancer Agency Fraser Valley Centre, Surrey, Canada
    J Clin Oncol 20:4242-8. 2002
    ..To determine the prevalence of and contributing factors for chronic arm morbidity including lymphedema in breast cancer patients after treatment and to assess the impact of arm morbidity on quality of life (QOL)...
  62. ncbi Age-related variations in the use of axillary dissection: a survival analysis of 8038 women with T1-ST2 breast cancer
    Pauline T Truong
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Cancer Centre, University of British Columbia, Victoria, British Columbia, Canada
    Int J Radiat Oncol Biol Phys 54:794-803. 2002
    ..The use of axillary dissection (AD) in women with invasive breast cancer is increasingly questioned. This study analyzes the survival in women with T1-2 breast cancer according to age and AD use...
  63. ncbi Treatment of invasive breast carcinoma with ultrasound-guided radiofrequency ablation
    Allen H Hayashi
    Department of Surgery, Vancouver Island Health Authority, Victoria, British Columbia, Canada
    Am J Surg 185:429-35. 2003
    ..Radiofrequency ablation (RFA) is a minimally invasive thermal ablation technique. This study reports the safety and efficacy of RFA as a minimally invasive strategy for breast cancers <3 cm diameter in postmenopausal women...
  64. ncbi Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy
    Pauline T Truong
    Radiation Therapy Program, British Columbia Cancer Agency Vancouver Island Centre and University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 61:1337-47. 2005
    ....
  65. ncbi Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial
    Cheri L Van Patten
    British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver Hospital and Health Sciences Centre, and University of British Columbia, Vancouver, British Columbia, Canada
    J Clin Oncol 20:1449-55. 2002
    ..This study evaluated the acceptability and effectiveness of a soy beverage containing phytoestrogens as a treatment for hot flashes in postmenopausal women with breast cancer...
  66. ncbi Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy
    Pauline T Truong
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, University of British Columbia, Victoria, BC, Canada
    Int J Radiat Oncol Biol Phys 62:175-82. 2005
    ..To identify patient subsets with T1-T2N0 breast cancer at high risk of locoregional recurrence (LRR) who may warrant consideration for postmastectomy radiotherapy...
  67. ncbi Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy
    Eric Berthelet
    Radiation Therapy Program, British Columbia Cancer Agency BCCA Vancouver Island, Canada
    Am J Clin Oncol 27:626-31. 2004
    ..The STAT is an easy-to-use, standardized instrument to evaluate acute skin reaction and may be applied to clinical care and research in patients undergoing radiotherapy...
  68. ncbi Health system costs of metastatic breast cancer
    E S Wai
    The Breast Cancer Outcomes Unit, British Columbia Cancer Agency, Vancouver, Canada
    Breast Cancer Res Treat 65:233-40. 2001
    ..Inpatient costs accounted for the greatest proportion of the total, over 50% in all age groups. This data may be valuable in assessing the cost-effectiveness of interventions that are known to affect mortality due to breast cancer...
  69. ncbi Consistency in seroma contouring for partial breast radiotherapy: impact of guidelines
    Elaine K Wong
    Radiation Therapy Program, British Columbia (BC) Cancer Agency, Vancouver Island Centre, Victoria and Vancouver, BC, Canada
    Int J Radiat Oncol Biol Phys 66:372-6. 2006
    ..CONCLUSION: Guidelines can improve consistency among radiation oncologists performing target volume delineation for PBRT planning...
  70. ncbi Facilitated "fast track" referral reduces time from abnormal screening mammogram to diagnosis
    Marilyn J Borugian
    Screening Mammography Program of British Columbia, British Columbia Cancer Agency, Vancouver, BC
    Can J Public Health 99:252-6. 2008
    ..The purpose of this study was to compare time intervals for patients evaluated through the Fast Track process with patients who were not...
  71. ncbi Correction of systematic setup errors in prostate radiation therapy: how many images to perform?
    Joanna J S Ludbrook
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, Victoria, BC, Canada
    Med Dosim 30:76-84. 2005
    ..A small tolerance level should be utilized with 2 mm giving good accuracy with minimal unnecessary shifts...
  72. ncbi Short communication: Setup variations in locoregional radiotherapy for breast cancer: an electronic portal imaging study
    P T Truong
    Radiation Therapy Program, British Columbia Cancer Agency, Vancouver Island Centre, 2410 Lee Avenue, Victoria, BC, Canada V8R 6V5
    Br J Radiol 78:742-5. 2005
    ..2% of breast/chest wall tangential treatments and in 6.2% of supraclavicular nodal treatments. These data demonstrate that EPI is a useful tool to verify setup reproducibility in LRRT for breast cancer...
  73. ncbi Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia
    Boon Chua
    BC Cancer Agency-Vancouver Island Centre and University of British Columbia, Vancouver, BC
    Can J Surg 46:273-8. 2003
    ..Developing consensus around written guidelines for the indications and techniques of SNB may reduce this variation...
  74. ncbi The quality of life of elderly women who underwent radiofrequency ablation to treat breast cancer
    Jillian Roberts
    University of Victoria, British Columbia, Canada
    Qual Health Res 16:762-72. 2006
    ..The level of support received from the medical team, family and friends, and other cancer survivors also improved participant quality of life...
  75. ncbi Measuring surgeon performance of sentinel lymph node biopsy in breast cancer treatment by cumulative sum analysis
    Lindsey Lerch
    Department of Surgery, Vancouver Island Health Authority, 302 2020 Richmond Road, Victoria, British Columbia, Canada V8R 6R5
    Am J Surg 193:556-9; discussion 560. 2007
    ..This study was performed to determine if surgeons' performance of sentinel lymph node biopsy (SLNB) for breast cancer varied with time and to devise a method to continuously evaluate that performance...
  76. ncbi Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
    Anthony W Fyles
    Department of Radiation Oncology, Princess Margaret Hospital, Toronto, ON, Canada
    N Engl J Med 351:963-70. 2004
    ..We determined the effect of breast irradiation plus tamoxifen on disease-free survival and local relapse in women 50 years of age or older who had T1 or T2 node-negative breast cancer...
  77. ncbi The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
    Kelly A Metcalfe
    Faculty of Nursing, University of Toronto, 50 St George Street, Toronto, ON, Canada, M5S 3H4
    Gynecol Oncol 96:222-6. 2005
    ..To estimate the risk of ovarian cancer after a primary diagnosis of breast cancer among women with a BRCA1 or BRCA2 mutation and to identify host and treatment-related factors that might modify the risk...
  78. ncbi Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer 103:1137-46. 2005
    ..The objective of the current study was to determine the long-term outcome after breast-conservation surgery followed by definitive breast irradiation for women with mammographically detected DCIS of the breast...
  79. ncbi Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
    Lori J Pierce
    Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI 48109 0010, USA
    J Clin Oncol 24:2437-43. 2006
    ..We compared the outcome of breast-conserving surgery and radiotherapy in BRCA1/2 mutation carriers with breast cancer versus that of matched sporadic controls...
  80. ncbi Time to stop progesterone receptor testing in breast cancer management
    Ivo A Olivotto
    J Clin Oncol 22:1769-70. 2004
  81. ncbi Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ
    Lawrence J Solin
    Department of Radiation Oncology, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Eur J Cancer 41:1715-23. 2005
    ..Close follow-up after initial breast conservation treatment with radiation is warranted for the early detection of potentially salvageable local and local-regional recurrences...
  82. ncbi Declining use of mastectomy for invasive breast cancer in Canada, 1981-2000
    Leslie A Gaudette
    Chronic Disease Management and Control Division, Centre for Chronic Disease Prevention and Control, Health Canada, Ottawa, ON
    Can J Public Health 95:336-40. 2004
    ..To evaluate the rate and magnitude of change in surgical practice for breast cancer in Canada in relation to publication dates of clinical trials and consensus conferences...
  83. ncbi Postmastectomy radiation therapy: who needs it?
    Ivo A Olivotto
    J Clin Oncol 22:4237-9. 2004
  84. ncbi Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy
    Pauline T Truong
    BC Cancer Agency-Vancouver Island Centre
    CMAJ 170:1263-73. 2004
    ..The final document was approved by the steering committee. SPONSOR: The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer was convened by Health Canada. COMPLETION DATE: November 2003...
  85. ncbi Staging reclassification affects breast cancer survival
    Ivo A Olivotto
    J Clin Oncol 21:4467-8. 2003
  86. ncbi Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial
    Joseph Ragaz
    McGill University Health Center, Royal Victoria Hospital, 687 Pine Ave, Montreal, PQ, Canada H3A 1A1
    J Natl Cancer Inst 97:116-26. 2005
    ..We report the analysis of data from the 20-year follow-up...
  87. ncbi Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type
    William D Foulkes
    Departments of Oncology, Sir M B Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    Clin Cancer Res 10:2029-34. 2004
    ..The relationship between ER status and other clinical features of hereditary breast cancers has not been well studied...
  88. ncbi In regard to Fortin et al., Int J Radiat Oncol Biol Phys 2003;56:1013-1022
    Ivo A Olivotto
    Int J Radiat Oncol Biol Phys 58:1317-8; author reply 1318. 2004
  89. ncbi Standardized audiotape versus recorded consultation to enhance informed consent to a clinical trial in breast oncology
    Thomas F Hack
    Faculty of Nursing, University of Manitoba, St Boniface Hospital Research Centre, 351 Tache Avenue, Winnipeg, MB, Canada
    Psychooncology 16:371-6. 2007
    ....
  90. ncbi Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma
    William D Foulkes
    Department of Oncology, McGill University, Montreal, Quebec, Canada
    Cancer 98:1569-77. 2003
    ..Therefore, the authors questioned whether the known positive correlation between tumor size and lymph node status also was present in women with BRCA1-related breast carcinomas...
  91. ncbi Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy
    Gordon F Schwartz
    Department of Surgery, Jefferson Medical College, Philadelphia, Pennsylvania 19107-4305, USA
    Cancer 107:242-50. 2006
  92. ncbi Consensus conference on breast conservation
    Gordon F Schwartz
    J Am Coll Surg 203:198-207. 2006